Anti-Addiction Vaccines: Big Profits for Drugmakers, Big Questions for Patients

clear glass tube with white plastic tube

Martha Rosenberg In its 2016 to 2020 strategic plan,  the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), promoted the promise of “anti-addiction vaccines “aimed at eliciting antibodies that block the effects of a specific drug.” The quest for an anti-addiction vaccine began in earnest when Drs. Nora D. […]